Loading...

Hu, Ke-Qin

TitleClinical Professor
InstitutionUniversity of California, Irvine
DepartmentMedicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-6926
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Suppression of Hepatoma Cell Growth by Celecoxib
    NIH/NCI R03CA095975Sep 1, 2003 - Aug 31, 2005
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Samarasena JB, Huang JY, Tsujino T, Thieu D, Yu A, Hu KQ, Lee J, Chang KJ. EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study. VideoGIE. 2018 Nov; 3(11):361-363. PMID: 30402586.
      View in: PubMed
    2. Wang H, Cooper BT, Schiff P, Sanfilippo NJ, Wu SP, Hu KS, Das IJ, Xue J. Dosimetric assessment of tumor control probability in intensity and volumetric modulated radiotherapy plans. Br J Radiol. 2018 Sep 13; 20180471. PMID: 30209959.
      View in: PubMed
    3. Mailhot Vega RB, Ishaq OF, Ahmed I, Rene L, Amendola BE, Hu KS. Novel Pilot Curriculum for International Education of Lymphoma Management Using E-Contouring. J Glob Oncol. 2018 Sep; (4):1-9. PMID: 30241149.
      View in: PubMed
    4. Hu KQ, Cui W. Persistence of Circulating Hepatitis C Virus Antigens-Specific Immune Complexes in Patients with Resolved HCV Infection. Dig Dis Sci. 2018 05; 63(5):1237-1242. PMID: 29516328.
      View in: PubMed
    5. Hu KS, Mourad WF, Gamez ME, Lin W, Jacobson AS, Persky MS, Urken ML, Culliney BE, Li Z, Tran TN, Schantz SP, Chadha J, Harrison LB. Five-year outcomes of an oropharynx-directed treatment approach for unknown primary of the head and neck. Oral Oncol. 2017 Jul; 70:14-22. PMID: 28622886.
      View in: PubMed
    6. Hu KS, Mourad WF, Gamez M, Safdieh J, Lin W, Jacobson AS, Persky MS, Urken ML, Culliney B, Li Z, Tran TN, Schantz SP, Chadha J, Harrison LB. Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization. Head Neck. 2017 Aug; 39(8):1647-1654. PMID: 28474380.
      View in: PubMed
    7. Huang JY, Samarasena JB, Tsujino T, Lee J, Hu KQ, McLaren CE, Chen WP, Chang KJ. EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study. Gastrointest Endosc. 2017 May; 85(5):996-1001. PMID: 27693644.
      View in: PubMed
    8. Wang C, Wang C, Jia ZF, Wu X, Wen SM, Kong F, Hu KQ, Li J, Jiang J, Niu JQ. Protective effect of an improved immunization practice of mother-to-infant transmission of hepatitis B virus and risk factors associated with immunoprophylaxis failure. Medicine (Baltimore). 2016 Aug; 95(34):e4390. PMID: 27559947.
      View in: PubMed
    9. Hu KQ, Cui W. A highly specific and sensitive hepatitis C virus antigen enzyme immunoassay for One-step diagnosis of viremic hepatitis C virus infection. Hepatology. 2016 08; 64(2):415-24. PMID: 27273268.
      View in: PubMed
    10. Zhang J, Nguyen D, Hu KQ. Chronic Hepatitis C Virus Infection: A Review of Current Direct-Acting Antiviral Treatment Strategies. N Am J Med Sci (Boston). 2016 Apr; 9(2):47-54. PMID: 27293521.
      View in: PubMed
    11. Morgan TR, Osann K, Bottiglieri T, Pimstone N, Hoefs JC, Hu KQ, Hassanein T, Boyer TD, Kong L, Chen WP, Richmond E, Gonzalez R, Rodriguez LM, Meyskens FL. A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum a-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP. Cancer Prev Res (Phila). 2015 Sep; 8(9):864-72. PMID: 26130251; PMCID: PMC4560676.
    12. Nguyen K, Van Nguyen T, Shen D, Xia V, Tran D, Banh K, Ruan V, Hu KQ. Prevalence and presentation of hepatitis B and C virus (HBV and HCV) infection in Vietnamese Americans via serial community serologic testing. J Immigr Minor Health. 2015 Feb; 17(1):13-20. PMID: 24474437.
      View in: PubMed
    13. Hu KQ. Advances in clinical application of cryoablation therapy for hepatocellular carcinoma and metastatic liver tumor. J Clin Gastroenterol. 2014 Nov-Dec; 48(10):830-6. PMID: 25148553.
      View in: PubMed
    14. Hu KQ. Advances in some common chronic liver diseases. Preface. Front Med. 2014 Jun; 8(2):127-8. PMID: 24871441.
      View in: PubMed
    15. Skupsky J, Hu KQ. Current hepatitis B treatment guidelines and future research directions. Front Med. 2014 Jun; 8(2):145-57. PMID: 24871443.
      View in: PubMed
    16. Gordon SC, Reddy KR, Jacobson IM, Poordad F, Bronowicki JP, Bacon B, Buti M, Hu KQ, Pedicone LD, Burroughs M, Brass CA, Albrecht JK, Lawitz EJ. Boceprevir plus peginterferon a-2b/ribavirin in chronic hepatitis C genotype 1: impact of baseline viral load on sustained virologic response. J Clin Gastroenterol. 2014 May-Jun; 48(5):435-43. PMID: 24177376.
      View in: PubMed
    17. Mourad WF, Hu KS, Shasha D, Concert C, Ishihara D, Lin W, Shourbaji RA, Ryniak M, Gamez ME, Lukens JN, Li Z, Culliney BE, Khorsandi AS, Tran T, Jacobson A, Manolidis S, Schantz S, Urken M, Persky MS, Harrison LB. Initial experience with oropharynx-targeted radiation therapy for metastatic squamous cell carcinoma of unknown primary of the head and neck. Anticancer Res. 2014 Jan; 34(1):243-8. PMID: 24403470.
      View in: PubMed
    18. Nguyen DL, Hu KQ. Clinical Monitoring of Chronic Hepatitis C Based on its Natural History and Therapy. N Am J Med Sci (Boston). 2014; 7(1):21-27. PMID: 25580186.
      View in: PubMed
    19. Hu KQ, Zhang YY. Impact of occult hepatitis B virus infection or hepatitis B virus DNA integration on efficacy of chronic hepatitis C treatment with peginterferon and ribavirin: where are we? J Clin Gastroenterol. 2014 Jan; 48(1):3-5. PMID: 24045272.
      View in: PubMed
    20. Mourad WF, Hauerstock D, Shourbaji RA, Hu KS, Culliney B, Li Z, Jacobson A, Tran T, Manolidis S, Schantz S, Urken M, Persky M, Harrison LB. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature. Am J Clin Oncol. 2013 Dec; 36(6):584-8. PMID: 22992621.
      View in: PubMed
    21. Mourad WF, Hu KS, Shourbaji RA, Woode R, Harrison LB. Long-term follow-up and pattern of failure for T1-T2 glottic cancer after definitive radiation therapy. Am J Clin Oncol. 2013 Dec; 36(6):580-3. PMID: 22868239.
      View in: PubMed
    22. Mourad WF, Shasha D, Blakaj DM, Khorsandi AS, Shourbaji RA, Glanzman J, Kabarriti R, Young R, Patel S, Katsoulakis E, Gámez M, Woode R, Lazarus C, Concert C, Hu KS, Harrison LB. Comprehensive head and neck radiotherapy dose-volume constraints do not apply to smaller volumes. Anticancer Res. 2013 Oct; 33(10):4483-9. PMID: 24123019.
      View in: PubMed
    23. Debenham BJ, Hu KS, Harrison LB. Present status and future directions of intraoperative radiotherapy. Lancet Oncol. 2013 Oct; 14(11):e457-e464. PMID: 24079873.
      View in: PubMed
    24. Chao DC, Hu KQ. Update on rescue therapies in patients with lamivudine-resistant chronic hepatitis B. Drug Des Devel Ther. 2013; 7:777-88. PMID: 23990707; PMCID: PMC3753145.
    25. Mourad WF, Young BM, Young R, Blakaj DM, Ohri N, Shourbaji RA, Manolidis S, Gámez M, Kumar M, Khorsandi A, Khan MA, Shasha D, Blakaj A, Glanzman J, Garg MK, Hu KS, Kalnicki S, Harrison LB. Clinical validation and applications for CT-based atlas for contouring the lower cranial nerves for head and neck cancer radiation therapy. Oral Oncol. 2013 Sep; 49(9):956-963. PMID: 23623404.
      View in: PubMed
    26. Mourad WF, Hu KS, Ishihara D, Shourbaji RA, Lin W, Kumar M, Jacobson AS, Tran T, Manolidis S, Urken M, Persky M, Harrison L. Tolerance and toxicity of primary radiation therapy in the management of seropositive HIV patients with squamous cell carcinoma of the head and neck. Laryngoscope. 2013 May; 123(5):1178-83. PMID: 23532683.
      View in: PubMed
    27. Mourad WF, Hu KS, Shourbaji RA, Ishihara D, Lin W, Kumar M, Blakaj DM, Harrison LB. The impact of computed tomography on early glottic cancer outcomes. Onkologie. 2013; 36(3):83-6. PMID: 23485994.
      View in: PubMed
    28. Wong PY, Xia V, Imagawa DK, Hoefs J, Hu KQ. Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans. J Immigr Minor Health. 2011 Oct; 13(5):842-8. PMID: 20890660; PMCID: PMC3155747.
    29. Hu KQ, Freilich B, Brown RS, Brass C, Jacobson IM. Impact of Hispanic or Asian ethnicity on the treatment outcomes of chronic hepatitis C: results from the WIN-R trial. J Clin Gastroenterol. 2011 Sep; 45(8):720-6. PMID: 21836471.
      View in: PubMed
    30. Hu KQ, Pan CQ, Goodwin D. Barriers to screening for hepatitis B virus infection in Asian Americans. Dig Dis Sci. 2011 Nov; 56(11):3163-71. PMID: 21861105.
      View in: PubMed
    31. Richter SM, Friedmann P, Mourad WF, Hu KS, Persky MS, Harrison LB. Postoperative radiation therapy for small, low-/intermediate-grade parotid tumors with close and/or positive surgical margins. Head Neck. 2012 Jul; 34(7):953-5. PMID: 21850698.
      View in: PubMed
    32. Samarasena JB, Hu KQ. Hepatobiliary manifestations of gastrointestinal and nutritional disorders. Clin Liver Dis. 2011 Feb; 15(1):89-110. PMID: 21111995.
      View in: PubMed
    33. Hu KQ, Schiff ER, Kowdley KV, Min AD, Shiffman ML, Lee WM, Goodman ZD, Dau LO, Peschell KJ, Fagan EA, Flaherty JF. Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels. J Clin Gastroenterol. 2010 Aug; 44(7):510-6. PMID: 20179614.
      View in: PubMed
    34. Mellen JS, Xia VW, Hashemzadeh M, Imagawa D, Jamal M, Hoefs J, Hu KQ. The clinical presentation of chronic hepatitis B virus infection in Asian Americans: a single center retrospective study. J Clin Gastroenterol. 2010 May-Jun; 44(5):364-70. PMID: 19770675.
      View in: PubMed
    35. Cui W, Chen SL, Hu KQ. Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells. Am J Transl Res. 2010 Jan 01; 2(1):95-104. PMID: 20182586; PMCID: PMC2826826.
    36. Cui W, Gu F, Hu KQ. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol. 2009 Apr 28; 15(16):1943-50. PMID: 19399925; PMCID: PMC2675083.
    37. Cui W, Hu SX, Tang ZY, Hu KQ. In-vivo effects and mechanisms of celecoxib-reduced growth of cyclooxygenase-2 (COX-2)-expressing versus COX-2-deleted human HCC xenografts in nude mice. Anticancer Drugs. 2008 Oct; 19(9):891-7. PMID: 18766003.
      View in: PubMed
    38. Hu KQ. Hepatitis B virus (HBV) infection in Asian and Pacific Islander Americans (APIAs): how can we do better for this special population? Am J Gastroenterol. 2008 Jul; 103(7):1824-33. PMID: 18479498.
      View in: PubMed
    39. Lah JJ, Cui W, Hu KQ. Effects and mechanisms of silibinin on human hepatoma cell lines. World J Gastroenterol. 2007 Oct 28; 13(40):5299-305. PMID: 17879397; PMCID: PMC4171317.
    40. Hu KQ, Currie SL, Shen H, Cheung RC, Ho SB, Bini EJ, McCracken JD, Morgan T, Bräu N, Schmidt WN, Jeffers L, Wright TL. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans. Dig Dis Sci. 2007 Feb; 52(2):570-8. PMID: 17226072.
      View in: PubMed
    41. Yoon EJ, Hu KQ. Hepatitis C virus (HCV) infection and hepatic steatosis. Int J Med Sci. 2006; 3(2):53-6. PMID: 16614743; PMCID: PMC1415843.
    42. Huang RH, Hu KQ. A practical approach to managing patients with HCV infection. Int J Med Sci. 2006; 3(2):63-8. PMID: 16614745; PMCID: PMC1415847.
    43. Cui W, Yu CH, Hu KQ. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells. Clin Cancer Res. 2005 Nov 15; 11(22):8213-21. PMID: 16299255.
      View in: PubMed
    44. Hu KQ, Lee SM, Hu SX, Xia VW, Hillebrand DJ, Kyulo NL. Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function. Am J Gastroenterol. 2005 Sep; 100(9):2010-8. PMID: 16128946.
      View in: PubMed
    45. Hu KQ. A Practical Approach to Management of Chronic Hepatitis B. Int J Med Sci. 2005; 2(1):17-23. PMID: 15968335.
      View in: PubMed
    46. Hu KQ, Yang H, Lin YC, Lindsay KL, Redeker AG. Clinical Profiles of Chronic Hepatitis C in a Major County Medical Center Outpatient Setting in United States. Int J Med Sci. 2004; 1(2):92-100. PMID: 15912201.
      View in: PubMed
    47. Hu KQ, Kyulo NL, Lim N, Elhazin B, Hillebrand DJ, Bock T. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol. 2004 May; 99(5):860-5. PMID: 15128351.
      View in: PubMed
    48. Hu KQ, Kyulo NL, Esrailian E, Thompson K, Chase R, Hillebrand DJ, Runyon BA. Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States. J Hepatol. 2004 Jan; 40(1):147-54. PMID: 14672626.
      View in: PubMed
    49. Hu KQ. Cyclooxygenase 2 (COX2)-prostanoid pathway and liver diseases. Prostaglandins Leukot Essent Fatty Acids. 2003 Nov; 69(5):329-37. PMID: 14580367.
      View in: PubMed
    50. Hu KS, Enker WE, Harrison LB. High-dose-rate intraoperative irradiation: current status and future directions. Semin Radiat Oncol. 2002 Jan; 12(1):62-80. PMID: 11813152.
      View in: PubMed